Arbutus Biopharma: Updates To Thesis Part 2 [Seeking Alpha]
Arbutus Biopharma Corporation (ABUS)
Last arbutus biopharma corporation earnings: 11/6 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.arbutusbio.com/node/5806
Company Research
Source: Seeking Alpha
Arbutus Biopharma: Updates To Thesis Part 2SummaryShares have risen over 25% in just two weeks since my previous update article and have doubled since my April recommendation.An important upcoming catalyst will be the presentation of detailed results in late October at the AASLD Annual Meeting.The company stands to receive significant royalties from Alnylam Pharmaceuticals that could go a long way in reducing ongoing losses (should patisiran be approved and launched successfully).The company received a significant vote of confidence from major shareholder Roivant Sciences in raising $116.4 million by selling convertible preferred stock.
Show less
Read more
Impact Snapshot
Event Time:
ABUS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABUS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABUS alerts
High impacting Arbutus Biopharma Corporation news events
Weekly update
A roundup of the hottest topics
ABUS
News
- Arbutus to Participate in Two Upcoming Investor ConferencesGlobeNewswire
- Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Arbutus Biopharma Co. (NASDAQ: ABUS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $4.00 price target on the stock.MarketBeat
- Arbutus Biopharma First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]Yahoo! Finance
- Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update [Financial Post (Toronto, Ontario, Canada)]Financial Post
ABUS
Earnings
- 5/2/24 - In-Line
ABUS
Sec Filings
- 5/2/24 - Form 10-Q
- 5/2/24 - Form 8-K
- 5/2/24 - Form 8-K
- ABUS's page on the SEC website